Home › Funds › Ally Bridge Group (NY) LLC › ABVX

Ally Bridge Group (NY) LLC position in ABVX

ABIVAX SA · Health Care

Ally Bridge Group (NY) LLC reported holding 125,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 14.73% of its reported portfolio and ranking #2 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)125.00K sh
Reported value held$16.66M
Portfolio Weight14.73%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's ABVX position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in ABVX in Q4 2025 at 70,000 shares (US$9.4M). The position peaked in Q2 2026 at 125,000 shares, worth US$16.7M. Across 3 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 125,000 shares valued at US$16.7M — an increase of 91,288 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2026 (shares rose 20% over the following quarter), a 271% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 70.00K $9.44M New
Q1 2026 33.71K $3.75M Reduce
Q2 2026 125.00K $16.66M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held ABVX?

Ally Bridge Group (NY) LLC has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Ally Bridge Group (NY) LLC's current position in ABVX?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 125.00K shares of ABVX (ABIVAX SA), valued at $16.66M, representing 14.73% of its reported portfolio and ranking #2.

Has Ally Bridge Group (NY) LLC been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC increased its position in ABVX. The position peaked in Q2 2026 at 125.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.